In 2016, Japanese cell biologist Yoshinori Ohsumi received the Nobel Prize in Physiology or Medicine for work conducted largely in the 1990s, using ordinary baker's yeast, that identified the genes controlling a cellular process called autophagy — literally "self-eating." Autophagy is the mechanism by which a cell identifies its own damaged, worn-out, or unnecessary internal components, encloses them in a membrane, and breaks them down for recycling into raw materials the cell can reuse. It is a fundamental piece of normal cell maintenance, operating continuously at a low level in nearly all cells, and it also increases sharply under specific stress conditions — nutrient scarcity prominent among them.
A Recycling System, Not a Fasting-Specific One
Autophagy is not something that switches on only during fasting; it is an ongoing housekeeping process essential to normal cell function, clearing out misfolded proteins and damaged organelles that would otherwise accumulate and impair the cell over time. What changes during periods of nutrient scarcity, including fasting, is the rate at which autophagy occurs. When a cell senses reduced availability of nutrients, particularly through a signalling pathway involving a protein complex called mTOR, which normally suppresses autophagy when nutrients are abundant, the drop in mTOR activity during fasting relieves that suppression and allows autophagy to proceed more actively — the cell shifting from a growth-focused state toward a maintenance and recycling-focused one.
What the Animal Research Actually Shows
Much of the evidence connecting increased autophagy to longer lifespan comes from model organisms — yeast, roundworms, fruit flies, and mice — in which genetically or dietarily increasing autophagy has, in numerous well-controlled studies, extended measured lifespan and improved markers of cellular health. This body of evidence is genuinely robust within those model systems, and it is the primary reason autophagy is taken so seriously in ageing research generally. The more complicated question, still substantially unresolved, is how directly these findings translate to fasting protocols in humans, where measuring autophagy directly is far more difficult, ethical and practical constraints limit the kinds of experiments possible, and the specific fasting durations, frequencies, and individual variation involved in most popular human fasting approaches have not been mapped onto autophagy activity with anything like the precision achieved in laboratory model organisms.
Where the Evidence Gets Thinner
Popular fasting and longevity content frequently presents human autophagy benefits as though they were as firmly established as the yeast and mouse research the field is built on. In reality, human studies on fasting-induced autophagy are fewer, generally smaller, and often rely on indirect biomarkers rather than direct measurement of autophagy activity in target tissues, which is considerably harder to assess safely in living people than in laboratory animals that can be sacrificed for direct tissue analysis. This does not mean fasting has no effect on human autophagy — the underlying cellular mechanism identified by Ohsumi's research is conserved across essentially all eukaryotic life, humans included, and reduced mTOR signalling during fasting almost certainly does increase autophagy to some degree — but the precise magnitude, optimal fasting duration, and resulting health outcomes in humans remain considerably less certain than confident popular claims often suggest.
A Real Mechanism, an Unfinished Story
Autophagy is one of the more elegant, well-established processes in modern cell biology, and its discovery genuinely earned its Nobel recognition. What remains open is not whether autophagy exists or matters — it clearly does — but how precisely to translate a mechanism characterised in yeast and mice into specific, evidence-based guidance for how and when humans should fast to meaningfully benefit from it, a gap that current human research has narrowed but not yet closed.